Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Preferred Shares (2023 - 2025)

INVO Fertility (IVF) has disclosed Preferred Shares for 3 consecutive years, with $8.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Preferred Shares rose 47.96% to $8.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.9 million, a 47.96% increase, with the full-year FY2024 number at $30.4 million, up 406.25% from a year prior.
  • Preferred Shares was $8.9 million for Q3 2025 at INVO Fertility, down from $10.1 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $30.4 million in Q4 2024 to a low of $500000.0 in Q1 2024.
  • A 3-year average of $12.3 million and a median of $7.4 million in 2023 define the central range for Preferred Shares.
  • Biggest YoY gain for Preferred Shares was 5975.0% in 2025; the steepest drop was 47.96% in 2025.
  • INVO Fertility's Preferred Shares stood at $6.0 million in 2023, then surged by 406.25% to $30.4 million in 2024, then crashed by 70.77% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Preferred Shares are $8.9 million (Q3 2025), $10.1 million (Q2 2025), and $30.4 million (Q1 2025).